China Drug, Device Makers See Higher Export Growth In Emerging Markets
This article was originally published in PharmAsia News
China makers of drugs and medical devices appear to be relying increasingly on emerging markets such as Africa, Russia and South America for sales growth, now accounting for a quarter of total exports.
You may also be interested in...
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
CureVac raised hundreds of millions of dollars this year before its $213m initial public offering as its mRNA vaccine technology moved into the COVID-19 spotlight. Its stock price tripled on its debut.